Chad Therapeutics (CHADQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -581 | -8,603 | -3,511 | -2,643 | -1,290 |
| Depreciation Amortization | 10 | 740 | 317 | 198 | 136 |
| Accounts receivable | 561 | 760 | 920 | 614 | 895 |
| Accounts payable and accrued liabilities | -21 | -820 | 225 | -424 | -551 |
| Other Working Capital | -654 | 2,045 | 1,283 | 639 | 1,082 |
| Other Operating Activity | -678 | 1,621 | -1,005 | -100 | -341 |
| Operating Cash Flow | $-1,363 | $-4,257 | $-1,771 | $-1,716 | $-69 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 4,032 | -151 | -86 | -20 |
| Purchase Sale Intangibles | -22 | N/A | -42 | N/A | -25 |
| Other Investing Activity | -22 | -355 | -42 | -30 | -25 |
| Investing Cash Flow | $-22 | $3,677 | $-193 | $-116 | $-45 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,750 | 1,168 | 1,094 | N/A |
| Debt Issued | N/A | 750 | 750 | 750 | N/A |
| Debt Repayment | N/A | -68 | -68 | N/A | N/A |
| Other Financing Activity | 0 | -1,159 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $2,273 | $1,850 | $1,844 | $N/A |
| Beginning Cash Position | 2,068 | 375 | 375 | 375 | 375 |
| End Cash Position | 683 | 2,068 | 261 | 387 | 261 |
| Net Cash Flow | $-1,385 | $1,693 | $-114 | $12 | $-114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,363 | -4,257 | -1,771 | -1,716 | -69 |
| Capital Expenditure | N/A | -161 | -151 | -86 | -20 |
| Free Cash Flow | -1,363 | -4,418 | -1,922 | -1,802 | -89 |